1. Home
  2. AXTI vs EVO Comparison

AXTI vs EVO Comparison

Compare AXTI & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AXT Inc

AXTI

AXT Inc

HOLD

Current Price

$32.54

Market Cap

1.1B

Sector

Technology

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$3.07

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AXTI
EVO
Founded
1986
1993
Country
United States
Germany
Employees
N/A
4766
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.3B
IPO Year
1998
N/A

Fundamental Metrics

Financial Performance
Metric
AXTI
EVO
Price
$32.54
$3.07
Analyst Decision
Hold
Strong Buy
Analyst Count
3
1
Target Price
$24.50
$7.00
AVG Volume (30 Days)
6.9M
133.2K
Earning Date
05-15-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
35.71
N/A
EPS
N/A
N/A
Revenue
$99,361,000.00
N/A
Revenue This Year
$44.70
N/A
Revenue Next Year
$42.23
$7.13
P/E Ratio
N/A
N/A
Revenue Growth
31.09
N/A
52 Week Low
$1.13
$2.84
52 Week High
$47.00
$4.80

Technical Indicators

Market Signals
Indicator
AXTI
EVO
Relative Strength Index (RSI) 53.36 37.40
Support Level $2.56 $2.87
Resistance Level N/A $3.78
Average True Range (ATR) 4.95 0.09
MACD 0.23 -0.05
Stochastic Oscillator 42.77 14.29

Price Performance

Historical Comparison
AXTI
EVO

About AXTI AXT Inc

AXT Inc is a developer and producer of compound and single element semiconductor substrates, also known as wafers. The dominant substrates used in producing semiconductor chips and other electronic circuits are made from silicon. It is engaged in the design, development, manufacture, and distribution of high-performance compound semiconductor substrates and the sale of materials. The company provides alternative or specialty materials in the form of substrates or wafers, including compound and single-element substrates. Its compound substrates combine indium with phosphorous or gallium with arsenic. Geographically firm has its business presence across the region of Europe, Japan, Taiwan, China, North America, and the Asia Pacific from which China derives its maximum revenue to the company.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: